High prevalence and molecular characterization of extended-spectrum β-lactamase-producing Proteus mirabilis strains in southern Croatia

Journal of Medical Microbiology

Volumn 59, Issue 10, 2010, Pages 1185-1190

  Tonkić, Marija ^a,b   Mohar, Bojana ^b   Šiško Kraljević, Katarina ^b,c   Meško Meglič, Karmen ^d   Goić Barišić, Ivana ^a,b   Novak, Anita ^a,b   Kovačić, Ana ^c   Punda Polić, Volga ^a,b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

^c Public Health Institute of Split and Dalmatia County   (Croatia)

^d UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; NETILMICIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BRONCHIAL ASPIRATION PROCEDURE; CONTROLLED STUDY; CROATIA; ENZYME INHIBITION; GENE AMPLIFICATION; GENOTYPE; HOSPITAL PATIENT; INTENSIVE CARE UNIT; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; NEUROSURGERY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS; URINALYSIS; BIOSYNTHESIS; BRONCHUS; ENZYMOLOGY; HUMAN; INJURY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROTEUS INFECTIONS; URINE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BRONCHI; CROATIA; DRUG RESISTANCE, BACTERIAL; HUMANS; PREVALENCE; PROTEUS INFECTIONS; PROTEUS MIRABILIS; URINE; WOUNDS AND INJURIES;

EID: 77957293101     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.016964-0     Document Type: Article

References (28)

1. Arlet, G., Brami, G., Décrè, D., Flippo, A., Gaillot, O., Lagrange, P. H. & Philippon, A. (1995). Molecular characterisation by PCR-restriction fragment length polymorphism of TEM β-lactamases. FEMS Microbiol Lett 134, 203-208.
2. Biendo, M., Thomas, D., Laurans, G., Hamdad-Daoudi, F., Canarelli, B., Rousseau, F., Castelain, S. & Eb, F. (2005). Molecular diversity of Proteus mirabilis isolates producing extended-spectrum β-lactamases in a French university hospital. Clin Microbiol Infect 11, 395-401.
3. Bonnet, R., De Champs, C., Sirot, D., Chanal, C., Labia, R. & Sirot, J. (1999). Diversity of TEM mutants in Proteus mirabilis. Antimicrob Agents Chemother 43, 2671-2677.
4. Bradford, P. A. (2001). Extended spectrum β-lactamases. Clin Microbiol Rev 14, 933-951.
5. Canton, R. & Coque, T. M. (2006). The CTX-M β-lactamase pandemic. Curr Opin Microbiol 9, 466-475.
6. CDC (2004). One-day (24-28 h) standardized laboratory protocol for molecular subtyping of Escherichia coli O157 : H7, non-typhoidal Salmonella serotypes, and Shigella sonnei by pulsed field gel electrophoresis. Atlanta: Centers for Disease Control and Prevention (http://www.cdc.gov/pulsenet/ protocols.htm)
7. CLSI (2008a). Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard, 10th edn, M02-A10. Wayne, PA: Clinical and Laboratory Standards Institute.
8. CLSI (2008b). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 8th edn, M07-A8. Wayne, PA: Clinical and Laboratory Standards Institute.
9. Coker, C., Poore, C. A., Li, X. & Mobely, H. L. (2000). Pathogenesis of Proteus mirabilis urinary tract infection. Microbes Infect 2, 1497-1505.
10. Empel, J., Baraniak, A., Literacka, E., Mrówka, A., Fiett, J., Sadowy, E., Hryniewicz, W., Gniadkowski, M. & the Beta-PL Study Group (2008). Molecular survey of β-lactamases conferring resistance to newer blactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob Agents Chemother 52, 2449-2454.
11. Fiett, J., Palucha, A., Miaczynska, B., Stankiewicz, M., Przondo- Mordarska, H., Hryniewicz, W. & Gniadkowski, M. (2000). A novel complex mutant β-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum β-lactamase-producing Klebsiellae. Antimicrob Agents Chemother 44, 1499-1505.
12. Ho, P. L., Chow, K. H., Yuen, K. Y., Ng, W. S. & Chau, P. Y. (1998). Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother 42, 49-54.
13. Jarlier, V., Nicolas, M. H., Fournier, G. & Philippon, A. (1988). Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10, 867-878.
14. Jean, S. S., Hsueh, P. R., Lee, W. S., Chang, H. T., Chou, M. Y., Chen, I. S., Wang, J. H., Lin, C. F., Shyr, J. M. & other authors (2009). Nationwide surveillance of antimicrobial resistance among Enterobacteriaceae in intensive care units in Taiwan. Eur J Clin Microbiol Infect Dis 28, 215-220.
15. Lau, S. H., Kaufmann, M. E., Livermore, D. M., Woodford, N., Willshaw, G. A., Cheasty, T., Stamper, K., Reddy, S., Cheesbrough, J. & other authors (2008). UK epidemic Escherichia coli strains A-E, with CTX-M-15 β-lactamase, all belong to the international O25 : H4-ST131 clone. J Antimicrob Chemother 62, 1241-1244.
16. Livermore, D. M. (1998). β-Lactamase-mediated resistance and opportunities for its control. J Antimicrob Chemother 41, 25-41.
17. Nijssen, S., Florijn, A., Bonten, M. J., Schmitz, F. J., Verhoef, J. & Fluit, A. C. (2004). Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents 24, 585-591.
18. Nüesch-Inderbinen, M. T., Hächler, H. & Kayser, F. H. (1996). Detection of genes coding for extended-spectrum SHV β-lactamases in clinical isolates by a molecular genetic method, and comparison with E test. Eur J Clin Microbiol Infect Dis 15, 398-402.
19. Pitout, J. D., Wei, Y., Church, D. L. & Gregson, D. B. (2008). Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(69)-Ib-cr. J Antimicrob Chemother 61, 999-1002.
20. Poyart, C., Mugnier, P., Quesne, G., Berche, P. & Trieu-Cuot, P. (1998). A novel extended-spectrum TEM-type β-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniae. Antimicrob Agents Chemother 42, 108-113.
21. Sardelic, S., Bedenic, B., Colinon, C., Sijak, D. & Kalenic, S. (2009). First report of TEM-52 lactamase in Proteus mirabilis strains from Croatia. Clin Microbiol Infect 15, 1204.
22. Spanu, T., Luzzaro, F., Perilli, M., Amicosante, G., Toniolo, A., Fadda, G. & the Italian ESBL Study Group (2002). Occurrence of extended-spectrum β-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to β-lactams and other antimicrobial drugs. Antimicrob Agents Chemother 46, 196-202.
23. Tonkic, M., Goic-Barisic, I. & Punda-Polic, V. (2005). Prevalence and antimicrobial resistance of extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae strains isolated in a university hospital in Split, Croatia. Int Microbiol 8, 119-124.
24. Tonkić, M., Goić-Barišić , I., Novak, A., Karanović, J., Šiško-Kraljević, K., Mohar, B. & Punda-Polić, V. (2008). Prevalence and antibiotic resistance of extended-spectrum β-lactamases (ESBLs)-producing Proteus mirabilis strains at University Hospital Split. In Abstracts Book of the 8th Croatian Congress of Clinical Microbiology with International Participation, Zagreb 25-28 May 2008, pp. 43-45. Edited by S. Kalenić. Zagreb: Croatian Society of Medical Microbiology and Parasitology.
25. Winokur, P. L., Canton, R., Casellas, J. M. & Legakis, N. (2001). Variation in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 32, S94-S103.
26. Woodford, N., Ward, M. E., Kaufmann, M. E., Turton, J., Fagan, E. J., James, D., Johnson, A. P., Pike, R., Warner, M. & other authors (2004). Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 54, 735-743.
27. Woodford, N., Fagan, E. J. & Ellington, M. J. (2005). Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J Antimicrob Chemother 57, 154-155.
28. CTX-M within an Australian extended-spectrum β-lactamase gene pool. Antimicrob Agents Chemother 52, 4198-4202.